MiMedx Group, Inc. Investment Income, Interest
MiMedx Group, Inc. (MDXG) reported Investment Income, Interest of $1.29 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-04-29
- MiMedx Group, Inc. investment income, interest for the quarter ending 2026-03-31 was $1.29M, a 30.89% increase year-over-year.
- MiMedx Group, Inc. investment income, interest for the quarter ending 2025-12-31 was $1.31M, a 41.67% increase year-over-year.
- MiMedx Group, Inc. investment income, interest for the quarter ending 2025-09-30 was $1.21M, a 51.44% increase year-over-year.
- MiMedx Group, Inc. investment income, interest for the quarter ending 2025-06-30 was $1.21M, a 131.05% increase year-over-year.
- MiMedx Group, Inc. investment income, interest for fiscal 2025 was $4.72M, a 60.85% increase from fiscal 2024.
- MiMedx Group, Inc. investment income, interest for fiscal 2024 was $2.93M, a 2384.75% increase from fiscal 2023.
- MiMedx Group, Inc. investment income, interest for fiscal 2023 was $118.00K, a 268.75% increase from fiscal 2022.
- MiMedx Group, Inc. investment income, interest for fiscal 2022 was $32.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.29M 10-Q · filed 2026-04-29 | $2.60M derived: sum of 2 quarters · filed 2026-04-29 | $3.81M derived: sum of 3 quarters · filed 2026-04-29 | $5.02M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.52M derived: sum of 2 quarters · filed 2026-02-25 | $3.73M derived: sum of 3 quarters · filed 2026-02-25 | $4.72M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.21M 10-Q · filed 2025-10-29 | $2.42M derived: sum of 2 quarters · filed 2025-10-29 | $3.41M 10-Q · filed 2025-10-29 | $4.33M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $1.21M 10-Q · filed 2025-07-30 | $2.20M 10-Q · filed 2025-07-30 | $3.12M derived: sum of 3 quarters · filed 2026-04-29 | $3.92M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $984.00K 10-Q · filed 2026-04-29 | $1.91M derived: sum of 2 quarters · filed 2026-04-29 | $2.71M derived: sum of 3 quarters · filed 2026-04-29 | $3.23M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $924.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.72M derived: sum of 2 quarters · filed 2026-02-25 | $2.25M derived: sum of 3 quarters · filed 2026-02-25 | $2.93M 10-K · filed 2026-02-25 |
| 2024-09-30 | $799.00K 10-Q · filed 2025-10-29 | $1.32M derived: sum of 2 quarters · filed 2025-10-29 | $2.01M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $525.00K 10-Q · filed 2025-07-30 | $1.21M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $684.00K 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $118.00K 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $32.00K 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |